Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery

INTRODUCTION: Advancement of novel anticancer drugs into clinical use is frequently halted by their lack of solubility, reduced stability under physiological conditions, and non-specific uptake by normal tissues, causing systemic toxicity. Their progress to use in the clinic could be accelerated by...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Nanomedicine
Main Authors: Breen, Alastair F, Scurr, David, Cassioli, Maria Letizia, Wells, Geoffrey, Thomas, Neil R, Zhang, Jihong, Turyanska, Lyudmila, Bradshaw, Tracey D
Format: Artigo
Jezik:Inglês
Izdano: Dove 2019
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6901036/
https://ncbi.nlm.nih.gov/pubmed/31824148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S226293
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki